GlobalData's clinical trial report, Relapsed Acute Myeloid Leukemia Global Clinical Trials Review, H1, 2014" provides data on the Relapsed Acute Myeloid Leukemia clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Relapsed Acute Myeloid Leukemia. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe.

1. Relapsed Acute Myeloid Leukemia Global Clinical Trials Review, H1, 2014
Relapsed Acute Myeloid Leukemia Global Clinical Trials Review, H1, 2014
Summary
GlobalData's clinical trial report, Relapsed Acute Myeloid Leukemia Global Clinical Trials Review, H1, 2014" provides data on the Relapsed Acute Myeloid
Leukemia clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Relapsed Acute Myeloid Leukemia. It
includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary
coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key
drugs for treating Relapsed Acute Myeloid Leukemia. This report is built using data and information sourced from proprietary databases, primary and secondary
research and in-house analysis by GlobalData's team of industry experts.
Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.
Scope
- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five
national contributions in each, along with the clinical trial scenario in BRIC nations
- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
- Listings of discontinued trials (suspended, withdrawn and terminated)
Reasons to buy
- Understand the dynamics of a particular indication in a condensed manner
- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
- Obtain discontinued trial listing for trials across the globe
- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies
Table Of Contents
table Of Contents 2
list Of Tables 4
list Of Figures 5
introduction 6
relapsed Acute Myeloid Leukemia 6
report Guidance 6
clinical Trials By Region 7
clinical Trials And Average Enrollment By Country 8
top Five Countries Contributing To Clinical Trials In Asia-pacific 10
top Five Countries Contributing To Clinical Trials In Europe 11
top Countries Contributing To Clinical Trials In North America 12
top Countries Contributing To Clinical Trials In Middle East And Africa 13
top Countries Contributing To Clinical Trials In Central And South America 14
clinical Trials By G7 Countries: Proportion Of Relapsed Acute Myeloid Leukemia To Oncology Clinical Trials 15
clinical Trials By Phase In G7 Countries 16
clinical Trials In G7 Countries By Trial Status 17
clinical Trials By E7 Countries: Proportion Of Relapsed Acute Myeloid Leukemia To Oncology Clinical Trials 18
clinical Trials By Phase In E7 Countries 19
clinical Trials In E7 Countries By Trial Status 20
clinical Trials By Phase 21
in Progress Trials By Phase 22
clinical Trials By Trial Status 23
clinical Trials By End Point Status 24
unaccomplished Trials Of Relapsed Acute Myeloid Leukemia 25
subjects Recruited Over A Period Of Time 27
clinical Trials By Sponsor Type 28
prominent Sponsors 29
top Companies Participating In Relapsed Acute Myeloid Leukemia Therapeutics Clinical Trials 30
prominent Drugs 32
latest Clinical Trials News On Relapsed Acute Myeloid Leukemia 33
aug 28, 2013: Astex Pharmaceuticals Announces Topline Results Of Sgi-110 Aml Phase 2 Study 33
jun 25, 2013: Fda Issues Partial Clinical Hold On Cell Therapeutics's Tosedostat For Treatment Of Blood Cancer 33
jun 13, 2013: Sunesis Pharma Announces Data And Safety Monitoring Board Recommends Continuation Of Valor Trial With No Change To Study Conduct 33
apr 01, 2013: Clavis Pharma Reports Negative Outcome Of Phase Iii Clavela Trial With Elacytarabine In Patients With Acute Myeloid Leukemia 34
nov 28, 2012: Coronado Biosciences Initiates Phase I/ii Trial Of Cndo-109 Activated Allogeneic Natural Killer Cells In Acute Myeloid Leukemia 34
clinical Trial Profiles 36
Relapsed Acute Myeloid Leukemia Global Clinical Trials Review, H1, 2014

2. clinical Trial Overview Of Top Companies 36
novartis Ag 36
clinical Trial Overview Of Novartis Ag 36
pfizer Inc. 38
clinical Trial Overview Of Pfizer Inc. 38
sanofi 39
clinical Trial Overview Of Sanofi 39
c. H. Boehringer Sohn Ag & Co. Kg 40
clinical Trial Overview Of C. H. Boehringer Sohn Ag & Co. Kg 40
ambit Biosciences Corporation 41
clinical Trial Overview Of Ambit Biosciences Corporation 41
f. Hoffmann-la Roche Ltd. 42
clinical Trial Overview Of F. Hoffmann-la Roche Ltd. 42
chroma Therapeutics Ltd. 43
clinical Trial Overview Of Chroma Therapeutics Ltd. 43
celator Pharmaceuticals, Inc. 44
clinical Trial Overview Of Celator Pharmaceuticals, Inc. 44
arog Pharmaceuticals Llc 45
clinical Trial Overview Of Arog Pharmaceuticals Llc 45
amgen Inc. 46
clinical Trial Overview Of Amgen Inc. 46
clinical Trial Overview Of Top Institutes / Government 47
national Cancer Institute 47
clinical Trial Overview Of National Cancer Institute 47
fred Hutchinson Cancer Research Center 50
clinical Trial Overview Of Fred Hutchinson Cancer Research Center 50
the University Of Texas M. D. Anderson Cancer Center 52
clinical Trial Overview Of The University Of Texas M. D. Anderson Cancer Center 52
children's Oncology Group 53
clinical Trial Overview Of Children's Oncology Group 53
washington University School Of Medicine 54
clinical Trial Overview Of Washington University School Of Medicine 54
stanford University 55
clinical Trial Overview Of Stanford University 55
roswell Park Cancer Institute 56
clinical Trial Overview Of Roswell Park Cancer Institute 56
university Of California, San Francisco 57
clinical Trial Overview Of University Of California, San Francisco 57
case Comprehensive Cancer Center 58
clinical Trial Overview Of Case Comprehensive Cancer Center 58
five Key Clinical Profiles 59
appendix 116
abbreviations 116
definitions 116
research Methodology 117
secondary Research 117
about Globaldata 118
contact Us 118
disclaimer 118
source 119
ResearchMoz(http://www.researchmoz.us/) is the one stop online destination to find and buy market research reports & Industry Analysis. We fulfill all your
research needs spanning across industry verticals with our huge collection of market research reports. We provide our services to all sizes of organizations and
across all industry verticals and markets. Our Research Coordinators have in-depth knowledge of reports as well as publishers and will assist you in making an
informed decision by giving you unbiased and deep insights on which reports will satisfy your needs at the best price.
Contact:
M/s Sheela,
90 State Street,
Suite 700,
Albany NY - 12207
United States
Tel: +1-518-618-1030
USA - Canada Toll Free 866-997-4948
Email: sales@researchmoz.us
Website: http://www.researchmoz.us/
Relapsed Acute Myeloid Leukemia Global Clinical Trials Review, H1, 2014